• 1
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 162538.
  • 2
    Hambly RJ, Rumney CJ, Cunninghame M, Fletcher JM, Rijken PJ, Rowland IR. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats. Carcinogenesis 1997; 18: 15359.
  • 3
    Reddy BS. Dietary fat, calories, and fiber in colon cancer. Prev Med 1993; 22: 73849.
  • 4
    Dommels YE, Heemskerk S, van den Berg H, Alink GM, van Bladeren PJ, van Ommen B. Effects of high fat fish oil and high fat corn oil diets on initiation of AOM-induced colonic aberrant crypt foci in male F344 rats. Food Chem Toxicol 2003; 41: 173947.
  • 5
    Raju J, Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res 2003; 63: 6595601.
  • 6
    Mutanen M, Pajari AM, Oikarinen SI. Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to β-catenin and PKC isozymes. Carcinogenesis 2000; 21: 116773.
  • 7
    Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 2002; 40: 119196.
  • 8
    Auwerx J. Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain? Am J Physiol Gastrointest Liver Physiol 2002; 282: G5815.
  • 9
    Brtko J, Thalhamer J. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention. Curr Pharm Des 2003; 9: 206777.
  • 10
    DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL, Lazar MA. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis 1998; 19: 4953.
  • 11
    Cote S, Momparler RL. Activation of the retinoic acid receptor beta gene by 5-aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs 1997; 8: 5661.
  • 12
    Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters JM. Peroxisome proliferator–activated receptor-delta attenuates colon carcinogenesis. Nat Med 2004; 10: 4813.
  • 13
    Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nature Rev Cancer 2001; 1: 18193.
  • 14
    Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis 2003; 24: 15418.
  • 15
    Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 2001; 22: 137983.
  • 16
    Girnun GD, Smith WM, Drori S, Sarraf P, Mueller E, Eng C, Nambiar P, Rosenberg DW, Bronson RT, Edelmann W, Kucherlapati R, Gonzalez FJ, et al. APC-dependent suppression of colon carcinogenesis by PPARγ. Proc Natl Acad Sci USA 2002; 99: 137716.
  • 17
    Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R, Xu XC. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002; 21: 41118.
  • 18
    Xiao JH, Ghosn C, Hinchman C, Forbes C, Wang J, Snider N, Cordrey A, Zhao Y, Chandraratna RA. Adenomatous polyposis coli (APC)–independent regulation of β-catenin degradation via a retinoid X receptor–mediated pathway. J Biol Chem 2003; 278: 2995462.
  • 19
    Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002; 41: 4155.
  • 20
    Mollersen L, Paulsen JE, Olstorn HB, Knutsen HK, Alexander J. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis 2004; 25: 14953.
  • 21
    Berraondo B, Marti A, Duncan JS, Trayhurn P, Martinez JA. Up-regulation of muscle UCP2 gene expression by a new β3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but downregulation in lean animals. Int J Obes Relat Metab Disord 2000; 24: 15663.
  • 22
    Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 14751.
  • 23
    Delage B, Groubet R, Pallet V, Bairras C, Higueret P, Cassand P. Vitamin A prevents high fat diet–induced ACF development and modifies the pattern of expression of peroxisome proliferator and retinoic acid receptor mRNA. Nutr Cancer 2004; 48: 2836.
  • 24
    Groubet R, Pallet V, Delage B, Redonnet A, Higueret P, Cassand P. Hyperlipidic diets induce early alterations of the vitamin A signalling pathway in rat colonic mucosa. Endocr Regul 2003; 37: 13744.
  • 25
    Bird RP, McLellan EA, Bruce WR. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 1989; 8: 189200.
  • 26
    Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191308.
  • 27
    Visek WJ, Clinton SK. Dietary protein and cancer. In: Alfin-SlaterRB, KritchevskyD, eds. Human nutrition a comprehensive treatise. Cancer and nutrition. vol. 7. New York: Plenum Press, 1991. 10326.
  • 28
    Clinton SK, Imrey PB, Mangian HJ, Nandkumar S, Visek WJ. The combined effects of dietary fat, protein, and energy intake on azoxymethane-induced intestinal and renal carcinogenesis. Cancer Res 1992; 52: 85765.
  • 29
    McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers GW. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 1995; 125: 80916.
  • 30
    McIntosh GH, Le Leu RK. Whey proteins protect more than red meat against azoxymethane induced ACF in Wistar rats. Cancer Lett 2003; 198: 4351.
  • 31
    Guillon F, Champ MM. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr 2002; 88: S293306.
  • 32
    Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. J Biosci 2002; 27: 70314.
  • 33
    Mathers JC, Mickleburgh I, Chapman PC, Bishop DT, Burn J. Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 study. Proc Nutr Soc 2003; 62: 517.
  • 34
    Lipkin M, Reddy B, Newmark H, Lamprecht SA. Dietary factors in human colorectal cancer. Annu Rev Nutr 1999; 19: 54586.
  • 35
    Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000; 112/113: 395402.
  • 36
    Weinstein IB. The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. Adv Second Messenger Phosphoprotein Res 1990; 24: 30716.
  • 37
    Brockman JA, Gupta RA, Dubois RN. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 1998; 115: 104955.
  • 38
    Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 1998; 4: 104652.
  • 39
    Yoshizumi T, Ohta T, Ninomiya I, Terada I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Yi S, Miwa K. Thiazolidinedione, a peroxisome proliferator–activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 2004; 25: 6319.
  • 40
    Kato M, Kusumi T, Tsuchida S, Tanaka M, Sasaki M, Kudo H. Induction of differentiation and peroxisome proliferator–activated receptor gamma expression in colon cancer cell lines by troglitazone. J Cancer Res Clin Oncol 2004; 130: 739.
  • 41
    Gimble JM, Pighetti GM, Lerner MR, Wu X, Lightfoot SA, Brackett DJ, Darcy K, Hollingsworth AB. Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands. Biochem Biophys Res Commun 1998; 253: 8137.
  • 42
    Badawi AF, Badr MZ. Expression of cyclooxygenase-2 and peroxisome proliferator–activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-δ12,14-prostaglandin J2 in human breast cancer and metastasis. Int J Cancer 2003; 103: 8490.
  • 43
    Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, et al. Effects of ligand activation of peroxisome proliferator–activated receptor gamma in human prostate cancer. Proc Natl Acad Sci USA 2000; 97: 109905.
  • 44
    Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C. Loss-of-function mutations in PPARγ associated with human colon cancer. Mol Cell 1999; 3: 799804.
  • 45
    Bogazzi F, Ultimieri F, Raggi F, Costa A, Gasperi M, Cecconi E, Mosca F, Bartalena L, Martino E. Peroxisome proliferator–activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 2002; 87: 24036.
  • 46
    Park BH, Vogelstein B, Kinzler KW. Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 2001; 98: 2598603.
  • 47
    Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001; 142: 4195202.
  • 48
    Lee MO, Han SY, Jiang S, Park JH, Kim SJ. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta. Biochem Pharmacol 2000; 59: 48596.
  • 49
    Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004; 41: 4178.
  • 50
    Randolph RK, Ross AC. Regulation of retinol uptake and esterification in MCF-7 and HepG2 cells by exogenous fatty acids. J Lipid Res 1991; 32: 80920.
  • 51
    Randolph RK, Simon M. Metabolic regulation of active retinoid concentrations in cultured human epidermal keratinocytes by exogenous fatty acids. Arch Biochem Biophys 1995; 318: 614.
  • 52
    Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 37859.
  • 53
    Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 25569.
  • 54
    Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 1997; 57: 346570.
  • 55
    Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 2003; 7: 20722.
  • 56
    Lustig B, Behrens J. The Wnt signalling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003; 129: 199221.
  • 57
    Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med. 1995; 332: 140510.
  • 58
    Folch J, Lees M, Sloanne GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497509.